data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Erasca
(NASDAQ:ERAS)
$5.82
0.25[4.49%]
At close: Jul 1
$5.82
00
After Hours: 4:02PM EDT
Day High/Low5.54 - 5.98
52 Week High/Low4.51 - 24.47
Open / Close5.54 / 5.82
Float / Outstanding76.9M / 121.9M
Vol / Avg.361K / 473.8K
Mkt Cap709.2M
P/E-
50d Avg. Price6.02
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float76.9M

Erasca (NASDAQ:ERAS), Quotes and News Summary

Erasca (NASDAQ: ERAS)

Day High/Low5.54 - 5.98
52 Week High/Low4.51 - 24.47
Open / Close5.54 / 5.82
Float / Outstanding76.9M / 121.9M
Vol / Avg.361K / 473.8K
Mkt Cap709.2M
P/E-
50d Avg. Price6.02
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float76.9M
Benzinga - Jun 2, 2022, 8:02AM
Benzinga - May 12, 2022, 4:14PM
Benzinga - Apr 12, 2022, 4:02PM
Benzinga - Mar 25, 2022, 10:33AM
Benzinga - Mar 24, 2022, 4:18PM
Benzinga - Mar 10, 2022, 8:11AM
Benzinga - Mar 8, 2022, 4:38PM
Benzinga - Dec 17, 2021, 8:08AM
Benzinga - Dec 14, 2021, 8:18AM
Benzinga - Nov 10, 2021, 4:41PM
Benzinga - Oct 25, 2021, 4:01PM
Benzinga - Sep 22, 2021, 8:01AM
Benzinga - Sep 9, 2021, 8:03AM
Benzinga - Sep 8, 2021, 8:26AM
load more
Sector: Health Care.Industry: Biotechnology
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-25
REV
Q1 2022Est.ActualSurprise
EPS-0.310
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Erasca Questions & Answers

Q
How do I buy Erasca (ERAS) stock?
A

You can purchase shares of Erasca (NASDAQ: ERAS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Erasca's (ERAS) competitors?
Q
What is the target price for Erasca (ERAS) stock?
A

The latest price target for Erasca (NASDAQ: ERAS) was reported by Evercore ISI Group on Tuesday, August 10, 2021. The analyst firm set a price target for 45.00 expecting ERAS to rise to within 12 months (a possible 673.20% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Erasca (ERAS)?
A

The stock price for Erasca (NASDAQ: ERAS) is $5.82 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Erasca (ERAS) pay a dividend?
A

There are no upcoming dividends for Erasca.

Q
When is Erasca (NASDAQ:ERAS) reporting earnings?
A

Erasca’s Q2 earnings are confirmed for Thursday, August 25, 2022.

Q
Is Erasca (ERAS) going to split?
A

There is no upcoming split for Erasca.

Q
What sector and industry does Erasca (ERAS) operate in?
A

Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.